Aarhus University Seal / Aarhus Universitets segl

Merete Lund Mægbæk

HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. / Rasmussen, L D; Dybdal, M; Gerstoft, J; Kronborg, G; Larsen, Carsten Schade; Pedersen, C; Pedersen, Gitte; Jensen, J; Pedersen, Lars; Sørensen, Henrik Toft; Obel, N.

In: HIV Medicine, Vol. 12, No. 4, 2011, p. 202-10.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Rasmussen, L D ; Dybdal, M ; Gerstoft, J ; Kronborg, G ; Larsen, Carsten Schade ; Pedersen, C ; Pedersen, Gitte ; Jensen, J ; Pedersen, Lars ; Sørensen, Henrik Toft ; Obel, N. / HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. In: HIV Medicine. 2011 ; Vol. 12, No. 4. pp. 202-10.

Bibtex

@article{870bd870b4f211dfb4b4000ea68e967b,
title = "HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study",
abstract = "Objective The association between HIV infection and the risk of venous thromboembolism (VTE) is controversial. We examined the risk of VTE in HIV-infected individuals compared with the general population and estimated the impact of low CD4 cell count, highly active antiretroviral therapy (HAART) and injecting drug use (IDU). Methods We identified 4333 Danish HIV-infected patients from the Danish HIV Cohort Study and a population-based age- and gender-matched comparison cohort of 43 330 individuals. VTE diagnoses were extracted from the Danish National Hospital Registry. Cumulative incidence curves were constructed for time to first VTE. Incidence rate ratios (IRRs) and impact of low CD4 cell count and HAART were estimated by Cox regression analyses. Analyses were stratified by IDU, adjusted for comorbidity and disaggregated by overall, provoked and unprovoked VTE. Results The 5-year risk of VTE was 8.0% [95% confidence interval (CI) 5.78-10.74%] in IDU HIV-infected patients, 1.5% (95% CI 1.14-1.95%) in non-IDU HIV-infected patients and 0.3% (95% CI 0.29-0.41%) in the population comparison cohort. In non-IDU HIV-infected patients, adjusted IRRs for unprovoked and provoked VTE were 3.42 (95% CI 2.58-4.54) and 5.51 (95% CI 3.29-9.23), respectively, compared with the population comparison cohort. In IDU HIV-infected patients, the adjusted IRRs were 12.66 (95% CI 6.03-26.59) for unprovoked VTE and 9.38 (95% CI 1.61-54.50) for provoked VTE. Low CD4 cell count had a minor impact on these risk estimates, while HAART increased the overall risk (IRR 1.93; 95% CI 1.00-3.72). Conclusion HIV-infected patients are at increased risk of VTE, especially in the IDU population. HAART and possibly low CD4 cell count further increase the risk.",
author = "Rasmussen, {L D} and M Dybdal and J Gerstoft and G Kronborg and Larsen, {Carsten Schade} and C Pedersen and Gitte Pedersen and J Jensen and Lars Pedersen and S{\o}rensen, {Henrik Toft} and N Obel",
year = "2011",
doi = "10.1111/j.1468-1293.2010.00869.x",
language = "English",
volume = "12",
pages = "202--10",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell Publishing Ltd.",
number = "4",

}

RIS

TY - JOUR

T1 - HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study

AU - Rasmussen, L D

AU - Dybdal, M

AU - Gerstoft, J

AU - Kronborg, G

AU - Larsen, Carsten Schade

AU - Pedersen, C

AU - Pedersen, Gitte

AU - Jensen, J

AU - Pedersen, Lars

AU - Sørensen, Henrik Toft

AU - Obel, N

PY - 2011

Y1 - 2011

N2 - Objective The association between HIV infection and the risk of venous thromboembolism (VTE) is controversial. We examined the risk of VTE in HIV-infected individuals compared with the general population and estimated the impact of low CD4 cell count, highly active antiretroviral therapy (HAART) and injecting drug use (IDU). Methods We identified 4333 Danish HIV-infected patients from the Danish HIV Cohort Study and a population-based age- and gender-matched comparison cohort of 43 330 individuals. VTE diagnoses were extracted from the Danish National Hospital Registry. Cumulative incidence curves were constructed for time to first VTE. Incidence rate ratios (IRRs) and impact of low CD4 cell count and HAART were estimated by Cox regression analyses. Analyses were stratified by IDU, adjusted for comorbidity and disaggregated by overall, provoked and unprovoked VTE. Results The 5-year risk of VTE was 8.0% [95% confidence interval (CI) 5.78-10.74%] in IDU HIV-infected patients, 1.5% (95% CI 1.14-1.95%) in non-IDU HIV-infected patients and 0.3% (95% CI 0.29-0.41%) in the population comparison cohort. In non-IDU HIV-infected patients, adjusted IRRs for unprovoked and provoked VTE were 3.42 (95% CI 2.58-4.54) and 5.51 (95% CI 3.29-9.23), respectively, compared with the population comparison cohort. In IDU HIV-infected patients, the adjusted IRRs were 12.66 (95% CI 6.03-26.59) for unprovoked VTE and 9.38 (95% CI 1.61-54.50) for provoked VTE. Low CD4 cell count had a minor impact on these risk estimates, while HAART increased the overall risk (IRR 1.93; 95% CI 1.00-3.72). Conclusion HIV-infected patients are at increased risk of VTE, especially in the IDU population. HAART and possibly low CD4 cell count further increase the risk.

AB - Objective The association between HIV infection and the risk of venous thromboembolism (VTE) is controversial. We examined the risk of VTE in HIV-infected individuals compared with the general population and estimated the impact of low CD4 cell count, highly active antiretroviral therapy (HAART) and injecting drug use (IDU). Methods We identified 4333 Danish HIV-infected patients from the Danish HIV Cohort Study and a population-based age- and gender-matched comparison cohort of 43 330 individuals. VTE diagnoses were extracted from the Danish National Hospital Registry. Cumulative incidence curves were constructed for time to first VTE. Incidence rate ratios (IRRs) and impact of low CD4 cell count and HAART were estimated by Cox regression analyses. Analyses were stratified by IDU, adjusted for comorbidity and disaggregated by overall, provoked and unprovoked VTE. Results The 5-year risk of VTE was 8.0% [95% confidence interval (CI) 5.78-10.74%] in IDU HIV-infected patients, 1.5% (95% CI 1.14-1.95%) in non-IDU HIV-infected patients and 0.3% (95% CI 0.29-0.41%) in the population comparison cohort. In non-IDU HIV-infected patients, adjusted IRRs for unprovoked and provoked VTE were 3.42 (95% CI 2.58-4.54) and 5.51 (95% CI 3.29-9.23), respectively, compared with the population comparison cohort. In IDU HIV-infected patients, the adjusted IRRs were 12.66 (95% CI 6.03-26.59) for unprovoked VTE and 9.38 (95% CI 1.61-54.50) for provoked VTE. Low CD4 cell count had a minor impact on these risk estimates, while HAART increased the overall risk (IRR 1.93; 95% CI 1.00-3.72). Conclusion HIV-infected patients are at increased risk of VTE, especially in the IDU population. HAART and possibly low CD4 cell count further increase the risk.

U2 - 10.1111/j.1468-1293.2010.00869.x

DO - 10.1111/j.1468-1293.2010.00869.x

M3 - Journal article

C2 - 20726905

VL - 12

SP - 202

EP - 210

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 4

ER -